Drug Profile
Dexrazoxane - Satiscor
Alternative Names: Dexrazoxane hydrochloride - SatiscorLatest Information Update: 13 Sep 2023
Price :
$50
*
At a glance
- Originator Satiscor
- Class Adjunct therapies; Chemoprotectants; Piperazines; Small molecules
- Mechanism of Action Iron chelating agents; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cardiomyopathies
Most Recent Events
- 13 Sep 2023 Discontinued - Preclinical for Cardiomyopathies (In adolescents, In children, In infants, Prevention) in USA (unspecified route) (Satiscor pipeline, September 2023)
- 28 Sep 2020 No recent reports of development identified for preclinical development in Cardiomyopathies(In adolescents, In children, In infants, Prevention) in USA
- 26 Aug 2016 Chemical structure information added